While TNF-α blockade has been effective in reducing inflammation and improving clinical outcomes in autoimmune diseases, it is important to note that some patients treated with selective TNF inhibitors may develop autoantibodies55,56. The gene discussed is TNF; the disease is autoimmune disease.